...
机译:表皮生长因子受体突变肺癌患者重复肺针活组织检查的安全性和成功
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Pathology Massachusetts General HospitalBoston Massachusetts USA;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Department of Radiology Division of Thoracic Imaging and Intervention Massachusetts General;
Massachusetts General Hospital Cancer Center Massachusetts General HospitalBoston Massachusetts USA;
Massachusetts General Hospital Cancer Center Massachusetts General HospitalBoston Massachusetts USA;
Non‐small cell lung cancer; Molecular targeted therapy; Disease progression; Needle biopsy; Complications;
机译:表皮生长因子受体突变肺癌患者重复肺针活组织检查的安全性和成功
机译:非小细胞肺癌的计算机断层扫描引导核心针穿刺活检的充分性和并发症证明表皮生长因子受体突变:18号或20号活检针
机译:卡巴替尼+厄洛替尼在晚期表皮生长因子受体(
机译:使用激光捕获微散射采购的细胞,使用激光捕获微粉的细胞的类固醇受体和生长因子受体表达
机译:酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
机译:表皮生长因子受体突变型肺癌患者重复肺穿刺活检的安全性和成功性
机译:淋巴细胞与单核细胞比率的基线和趋势作为表皮生长因子受体突变非小细胞肺癌患者用一线表皮生长因子受体酪氨酸激酶抑制剂治疗的预后因素。